NTL HEALTHCARE Expands African Market Presence with CerviCARE AI

South Korean company NTL HEALTHCARE has reinforced its expansion into the African market following its participation in WHX Johannesburg 2026 in South Africa. The company showcased its artificial intelligence-powered cervical screening system, CerviCARE AI, aiming to enhance cancer screening efficiency and accessibility across the continent.

During the event, NTL HEALTHCARE engaged in discussions with over 200 organizations regarding the adoption of CerviCARE AI. The company's objective is to improve access to quality healthcare services in Africa by leveraging AI for the early detection of cervical cancer. The system reportedly offers faster and more accurate diagnostics compared to traditional methods.

The expansion into the South African market is a key component of NTL HEALTHCARE's strategy. The company believes CerviCARE AI can significantly reduce the incidence of cervical cancer in a region where the disease remains a major public health concern. Initial discussions with local health authorities and organizations have reportedly shown promise.

WHX Johannesburg 2026 provided NTL HEALTHCARE with a platform to forge new partnerships and strengthen relationships with existing stakeholders in the African healthcare sector. The company intends to continue its efforts to commercialize CerviCARE AI and increase its availability within the region.